Biohaven Pharmaceutical Holding Form 5 Biohaven Pharmaceutical Holding / Declan Doogan ownership change

SEC Form 5

FORM 5

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

ANNUAL STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0362
Estimated average burden
hours per response:	1.0

X

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Form 3 Holdings Reported.

Form 4 Transactions Reported.

1. Name and Address of Reporting Person^*

Doogan Declan

(Last) (First) (Middle)

C/O BIOHAVEN PHARMACEUTICALS, INC.

215 CHURCH STREET

(Street)

NEW HAVEN CT 06510

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Biohaven Pharmaceutical Holding Co Ltd. [ BHVN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Statement for Issuer's Fiscal Year Ended (Month/Day/Year)
12/31/2021

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)	4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned at end of Issuer's Fiscal Year (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
				Amount	(A) or (D)	Price
Common Shares	03/08/2021		G	210,000	D	$0.00	610,647	D
Common Shares	03/08/2021		G	140,000	A	$0.00	140,000	I	Declan Doogan Revocable Trust
Common Shares	03/08/2021		G	70,000	A	$0.00	70,000	I	Dorothy Doogan Revocable Trust
Common Shares	03/16/2021		G	60,775	A	$0.00	60,775	I	Dorothy Doogan 2020 Trust
Common Shares	03/16/2021		G	60,775	D	$0.00	9,225	I	Dorothy Doogan Revocable Trust
Common Shares	03/18/2021		G	139,916	A	$0.00	139,916	I	Declan Doogan 2021 Trust
Common Shares	03/18/2021		G	139,916	D	$0.00	84	I	Declan Doogan Revocable Trust
Common Shares	03/22/2021		G	22,315	D	$0.00	38,460	I	Dorothy Doogan 2020 Trust
Common Shares	03/22/2021		G	22,315	A	$0.00	31,540	I	Dorothy Doogan Revocable Trust
Common Shares	03/24/2021		G	132,901	D	$0.00	7,015	I	Declan Doogan 2021 Trust
Common Shares	03/24/2021		G	132,901	A	$0.00	132,985	I	Declan Doogan Revocable Trust
Common Shares	05/18/2021		G	113,912	D	$0.00	496,735	D
Common Shares	05/18/2021		G	113,912	A	$0.00	246,897	I	Declan Doogan Revocable Trust
Common Shares	05/18/2021		G	31,540	A	$0.00	278,437	I	Declan Doogan Revocable Trust
Common Shares	05/18/2021		G	20,800	D	$0.00	17,660	I	Dorothy Doogan 2020 Trust
Common Shares	05/18/2021		G	20,800	A	$0.00	52,340	I	Dorothy Doogan Revocable Trust
Common Shares	05/18/2021		G	31,540	D	$0.00	20,800	I	Dorothy Doogan Revocable Trust
Common Shares	05/21/2021		I	170,000	D	$0.00	108,437	I	Declan Doogan Revocable Trust
Common Shares	05/21/2021		G	20,800	A	$0.00	129,237	I	Declan Doogan Revocable Trust
Common Shares	05/21/2021		I	170,000	A	$0.00	187,660	I	Dorothy Doogan 2020 Trust
Common Shares	05/21/2021		G	20,800	D	$0.00	0.00	I	Dorothy Doogan Revocable Trust
Common Shares	10/14/2021		G	7,015	D	$0.00	0.00	I	Declan Doogan 2021 Trust
Common Shares	10/14/2021		G	7,015	A	$0.00	136,252	I	Declan Doogan Revocable Trust
Common Shares	10/14/2021		G	7,342	D	$0.00	180,318	I	Dorothy Doogan 2020 Trust
Common Shares	10/14/2021		G	7,342	A	$0.00	7,342	I	Dorothy Doogan Revocable Trust
Common Shares	11/22/2021		G	491,260	D	$0.00	5,475	D
Common Shares	11/22/2021		G	491,260	A	$0.00	627,512	I	Declan Doogan Revocable Trust
Common Shares	11/30/2021		G	5,475	D	$0.00	0.00	D
Common Shares	11/30/2021		G	5,475	A	$0.00	632,987	I	Declan Doogan Revocable Trust
Common Shares							676,002	I	By the Declan Doogan 2014 Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)	5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
					(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Jim Engelhart, Attorney-in-Fact	02/11/2022
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.